Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 21 studies | 63% ± 20% | |
lung | 20 studies | 49% ± 13% | |
peripheral blood | 16 studies | 33% ± 12% | |
intestine | 12 studies | 36% ± 19% | |
eye | 12 studies | 62% ± 24% | |
kidney | 10 studies | 45% ± 14% | |
heart | 6 studies | 26% ± 8% | |
liver | 6 studies | 37% ± 13% | |
bone marrow | 5 studies | 34% ± 17% | |
uterus | 5 studies | 54% ± 13% | |
adipose | 5 studies | 49% ± 24% | |
prostate | 5 studies | 63% ± 24% | |
breast | 5 studies | 53% ± 17% | |
placenta | 4 studies | 69% ± 23% | |
esophagus | 4 studies | 49% ± 24% | |
lymph node | 4 studies | 44% ± 19% | |
pancreas | 3 studies | 70% ± 19% | |
adrenal gland | 3 studies | 31% ± 4% | |
thymus | 3 studies | 47% ± 22% | |
skin | 3 studies | 55% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 28306.99 | 459 / 459 | 100% | 193.52 | 1118 / 1118 |
esophagus | 100% | 18663.37 | 1445 / 1445 | 100% | 139.68 | 183 / 183 |
brain | 100% | 38897.48 | 2640 / 2642 | 100% | 273.19 | 705 / 705 |
kidney | 100% | 17894.36 | 89 / 89 | 100% | 196.09 | 900 / 901 |
uterus | 100% | 16095.32 | 170 / 170 | 100% | 137.18 | 458 / 459 |
lung | 100% | 24390.52 | 576 / 578 | 100% | 138.54 | 1155 / 1155 |
adrenal gland | 100% | 31858.46 | 258 / 258 | 100% | 196.65 | 229 / 230 |
intestine | 100% | 17389.76 | 965 / 966 | 100% | 112.46 | 525 / 527 |
bladder | 100% | 27275.38 | 21 / 21 | 99% | 156.35 | 501 / 504 |
prostate | 100% | 15545.77 | 244 / 245 | 100% | 138.09 | 500 / 502 |
ovary | 100% | 13249.52 | 180 / 180 | 99% | 81.75 | 426 / 430 |
thymus | 99% | 13544.15 | 648 / 653 | 99% | 108.31 | 599 / 605 |
skin | 100% | 30696.47 | 1807 / 1809 | 98% | 131.95 | 462 / 472 |
liver | 88% | 9848.64 | 199 / 226 | 99% | 110.88 | 400 / 406 |
stomach | 87% | 10968.54 | 314 / 359 | 99% | 105.84 | 282 / 286 |
pancreas | 54% | 3459.55 | 177 / 328 | 99% | 147.74 | 176 / 178 |
adipose | 100% | 34566.68 | 1204 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 93.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 61.36 | 1 / 1 |
blood vessel | 100% | 25586.57 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 22218.12 | 793 / 803 | 0% | 0 | 0 / 0 |
spleen | 98% | 9047.17 | 236 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 58.98 | 26 / 29 |
eye | 0% | 0 | 0 / 0 | 85% | 71.72 | 68 / 80 |
heart | 79% | 10729.86 | 681 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 74% | 7696.37 | 685 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1990809 | Biological process | endoplasmic reticulum tubular network membrane organization |
GO_0071786 | Biological process | endoplasmic reticulum tubular network organization |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0071787 | Biological process | endoplasmic reticulum tubular network formation |
GO_1905552 | Biological process | positive regulation of protein localization to endoplasmic reticulum |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0051292 | Biological process | nuclear pore complex assembly |
GO_2000172 | Biological process | regulation of branching morphogenesis of a nerve |
GO_0060317 | Biological process | cardiac epithelial to mesenchymal transition |
GO_0007413 | Biological process | axonal fasciculation |
GO_0030182 | Biological process | neuron differentiation |
GO_0090156 | Biological process | intracellular sphingolipid homeostasis |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0034165 | Biological process | positive regulation of toll-like receptor 9 signaling pathway |
GO_0061462 | Biological process | protein localization to lysosome |
GO_0050821 | Biological process | protein stabilization |
GO_1905580 | Biological process | positive regulation of ERBB3 signaling pathway |
GO_0007420 | Biological process | brain development |
GO_0006915 | Biological process | apoptotic process |
GO_0030517 | Biological process | negative regulation of axon extension |
GO_0033601 | Biological process | positive regulation of mammary gland epithelial cell proliferation |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0001825 | Biological process | blastocyst formation |
GO_0010634 | Biological process | positive regulation of epithelial cell migration |
GO_0021801 | Biological process | cerebral cortex radial glia-guided migration |
GO_0030308 | Biological process | negative regulation of cell growth |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0071782 | Cellular component | endoplasmic reticulum tubular network |
GO_0005635 | Cellular component | nuclear envelope |
GO_0043005 | Cellular component | neuron projection |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0045202 | Cellular component | synapse |
GO_0070161 | Cellular component | anchoring junction |
GO_0014069 | Cellular component | postsynaptic density |
GO_0098826 | Cellular component | endoplasmic reticulum tubular network membrane |
GO_0045296 | Molecular function | cadherin binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | RTN4 |
Protein name | Reticulon 4 Reticulon Uncharacterized protein RTN4 Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5) |
Synonyms | My043 KIAA0886 NOGO SP1507 |
Description | FUNCTION: Required to induce the formation and stabilization of endoplasmic reticulum (ER) tubules . They regulate membrane morphogenesis in the ER by promoting tubular ER production . They influence nuclear envelope expansion, nuclear pore complex formation and proper localization of inner nuclear membrane proteins . However each isoform have specific functions mainly depending on their tissue expression specificities (Probable). .; FUNCTION: [Isoform A]: Developmental neurite growth regulatory factor with a role as a negative regulator of axon-axon adhesion and growth, and as a facilitator of neurite branching. Regulates neurite fasciculation, branching and extension in the developing nervous system. Involved in down-regulation of growth, stabilization of wiring and restriction of plasticity in the adult CNS . Regulates the radial migration of cortical neurons via an RTN4R-LINGO1 containing receptor complex (By similarity). Acts as a negative regulator of central nervous system angiogenesis. Inhibits spreading, migration and sprouting of primary brain microvascular endothelial cells (MVECs). Also induces the retraction of MVECs lamellipodia and filopodia in a ROCK pathway-dependent manner (By similarity). .; FUNCTION: [Isoform B]: Mainly function in endothelial cells and vascular smooth muscle cells, is also involved in immune system regulation (Probable). Modulator of vascular remodeling, promotes the migration of endothelial cells but inhibits the migration of vascular smooth muscle cells. Regulates endothelial sphingolipid biosynthesis with direct effects on vascular function and blood pressure. Inhibits serine palmitoyltransferase, SPTLC1, the rate-limiting enzyme of the novo sphingolipid biosynthetic pathway, thereby controlling production of endothelial sphingosine-1-phosphate (S1P). Required to promote macrophage homing and functions such as cytokine/chemokine gene expression involved in angiogenesis, arteriogenesis and tissue repair. Mediates ICAM1 induced transendothelial migration of leukocytes such as monocytes and neutrophils and acute inflammation. Necessary for immune responses triggered by nucleic acid sensing TLRs, such as TLR9, is required for proper TLR9 location to endolysosomes. Also involved in immune response to LPS. Plays a role in liver regeneration through the modulation of hepatocytes proliferation (By similarity). Reduces the anti-apoptotic activity of Bcl-xl and Bcl-2. This is likely consecutive to their change in subcellular location, from the mitochondria to the endoplasmic reticulum, after binding and sequestration . With isoform C, inhibits BACE1 activity and amyloid precursor protein processing . .; FUNCTION: [Isoform C]: Regulates cardiomyocyte apoptosis upon hypoxic conditions (By similarity). With isoform B, inhibits BACE1 activity and amyloid precursor protein processing . . |
Accessions | ENST00000394611.6 [Q9NQC3-6] Q53RF4 ENST00000357732.8 [Q9NQC3-5] ENST00000394609.6 [Q9NQC3-3] Q53R94 Q9NQC3 ENST00000427710.5 ENST00000337526.11 [Q9NQC3-1] ENST00000405240.5 [Q9NQC3-6] A0A0U1RQR6 C9J685 ENST00000357376.7 [Q9NQC3-6] ENST00000317610.11 [Q9NQC3-2] Q6IPN0 H7C106 ENST00000486085.5 ENST00000438462.1 ENST00000404909.5 [Q9NQC3-6] Q53SY1 |